Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-12-02
1999-06-08
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 13, 514 14, 514 15, 514 16, 514 17, 514 18, 514 19, 514318, 514332, A61K 3141, A61K 3800, A61K 31445, A61K 3144
Patent
active
059105054
ABSTRACT:
This invention provides methods for the treatment or inhibitor of oral squamous cell carcinoma which comprises administering to a mammal in need thereof an effective amount of a compound having activity as a leukotriene B.sub.4 antagonist.
REFERENCES:
patent: 5158971 (1992-10-01), Clarke et al.
patent: 5462954 (1995-10-01), Baker et al.
Hakim, et al., British Journal of Oral and Maxillofacial Surgery, 23:155-159 (1990).
Fleisch Jerome H.
Jackson William T.
Sawyer Jason S.
Eli Lilly and Company
Goldberg Jerome D.
Lentz Nelsen L.
Palmberg Arleen
LandOfFree
Leukotriene antagonists for use in the treatment or inhibition o does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Leukotriene antagonists for use in the treatment or inhibition o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Leukotriene antagonists for use in the treatment or inhibition o will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1683480